| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | Whilst the Fund's primary strategy is focused on long/short equities, the ability to retain discretionary powers to allocate across a number of other investment strategies is reserved. These strategies may include, but not be limited to: convertible bond investments, portfolio hedging, equity related arbitrage, special situations (e.g. merger arbitrage, rights offerings, participation in international public offerings and placements, etc.). The Fund's geographic focus is Asia excluding Japan, but including Australia). The Fund may invest outside of this region to the extent that: 1. The investment decision is driven from the Asian region or; 2. The exposure is intended to mitigate risk or enhance return from factors external to the Asian region. |
| Manager Comments | The Fund's strong focus on downside protection is illustrated by its Sortino ratio of 4.06 versus the Index's 0.49, average negative return of -0.81% versus the Index's -2.72% and down-capture ratio of -88.53% (a negative down-capture ratio indicates that, on average, the Fund has risen during the months the market has fallen). In addition, since inception the largest drawdown the Fund has experienced was -2.69% whereas over the same period that of the market was -15.13%. The main positive contributor for the month was Avita Medical Ltd (AVH.AX) which contributed +77bp. Across other positions no one name contributed or detracted more than 30bp. |
| More Information |
